+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID07105202

Study of Levosimendan to Shorten Mechanical Ventilation Time in Critically Ill Adults

Led by Radboud University Medical Center · Updated on 2026-01-09

250

Participants Needed

8

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of levosimendan to help patients in intensive care units who are having difficulty stopping mechanical ventilation. The study focuses on adults who have been on a ventilator for more than 48 hours and failed at least one attempt to breathe on their own. The trial aims to see if levosimendan can improve diaphragm function and shorten the time patients need mechanical ventilation compared to a placebo. Participants will be randomly assigned to receive either levosimendan or a placebo called Soluvit, both given as a continuous intravenous infusion over 24 hours. The starting dose is 0.1 gkgmin, which may increase to 0.2 gkgmin after 4 hours if tolerated. If weaning from ventilation is not successful within 7 days, up to four treatment cycles may be given. All patients continue to receive standard ICU care with daily assessments for readiness to wean. During the study, researchers will collect data from medical records and routine monitoring without extra invasive procedures. They will assess ventilator-free days up to 28 days after randomization as the main outcome, along with other measures like ventilator-free days up to 90 days, dyspnea scores after extubation, reintubation rates, ICU and hospital length of stay, and mortality. Quality of life will be evaluated at baseline, 3 months, and 12 months. Safety monitoring includes heart rhythm, blood pressure, and adverse events related to the study drug.

CONDITIONS

Brief Title

Shorter Weaning From Invasive Ventilation With Levosimendan

Research Team

E

Esther de Leijer, MD

L

Leo Heunks, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here